| 摘要 |
The invention relates to medicine and pharmacology and can be used for the preparation of novel medicinal agents with nootropic, anticholesterosis activity and neuromuscular transmission stimulating action. The agent contains 9-butylamino-3,3-dimethyl-3,4-dihydro(2H)acridine-1-OH chlorohydrate (bucridon hydrochloride) as active substance in amount of 0.005-0.06 mg and a pharmaceutically acceptable base. |
